OOIR: Observatory of International Research

Papers

(The median citation count of Viruses-Basel is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Monkeypox Virus in Nigeria: Infection Biology, Epidemiology, and Evolution	506
COVID-19: A Review on the Novel Coronavirus Disease Evolution, Transmission, Detection, Control and Prevention	403
A Roadmap for Genome-Based Phage Taxonomy	328
VIRIDIC—A Novel Tool to Calculate the Intergenomic Similarities of Prokaryote-Infecting Viruses	287
Long-COVID and Post-COVID Health Complications: An Up-to-Date Review on Clinical Conditions and Their Possible Molecular Mechanisms	279
Domains and Functions of Spike Protein in SARS-Cov-2 in the Context of Vaccine Design	239
The SARS-CoV-2 Nucleocapsid Protein and Its Role in Viral Structure, Biological Functions, and a Potential Target for Drug or Vaccine Mitigation	220
Comparison of Rapid Antigen Tests for COVID-19	173
Neuroinvasion and Encephalitis Following Intranasal Inoculation of SARS-CoV-2 in K18-hACE2 Mice	170
Herpes zoster: A Review of Clinical Manifestations and Management	158
Highly Pathogenic Avian Influenza Viruses at the Wild–Domestic Bird Interface in Europe: Future Directions for Research and Surveillance	151
Immune Evasion of SARS-CoV-2 Emerging Variants: What Have We Learnt So Far?	149
Mutations and Evolution of the SARS-CoV-2 Spike Protein	148
Antibody Response to the BNT162b2 mRNA COVID-19 Vaccine in Subjects with Prior SARS-CoV-2 Infection	138
A Detailed Overview of SARS-CoV-2 Omicron: Its Sub-Variants, Mutations and Pathophysiology, Clinical Characteristics, Immunological Landscape, Immune Escape, and Therapies	133
Glycyrrhizin Effectively Inhibits SARS-CoV-2 Replication by Inhibiting the Viral Main Protease	132
Attitudes towards Anti-SARS-CoV2 Vaccination among Healthcare Workers: Results from a National Survey in Italy	132
The Advantages and Challenges of Using Endolysins in a Clinical Setting	131
Impaired Humoral Response in Renal Transplant Recipients to SARS-CoV-2 Vaccination with BNT162b2 (Pfizer-BioNTech)	130
SARS-CoV-2 Nucleocapsid Protein Interacts with RIG-I and Represses RIG-Mediated IFN-β Production	128
Endothelium Infection and Dysregulation by SARS-CoV-2: Evidence and Caveats in COVID-19	126
Resveratrol Inhibits HCoV-229E and SARS-CoV-2 Coronavirus Replication In Vitro	123
Here, There, and Everywhere: The Wide Host Range and Geographic Distribution of Zoonotic Orthopoxviruses	118
Placental Pathology of COVID-19 with and without Fetal and Neonatal Infection: Trophoblast Necrosis and Chronic Histiocytic Intervillositis as Risk Factors for Transplacental Transmission of SARS-CoV-	115
SARS-CoV-2 Infections and Viral Isolations among Serially Tested Cats and Dogs in Households with Infected Owners in Texas, USA	114

Long-COVID Symptoms in Individuals Infected with Different SARS-CoV-2 Variants of Concern: A Systematic Review of the Literature	105
Structure-Function Analyses of New SARS-CoV-2 Variants B.1.1.7, B.1.351 and B.1.1.28.1: Clinical, Diagnostic, Therapeutic and Public Health Implications	105
The Mechanism behind Influenza Virus Cytokine Storm	104
African Swine Fever in Wild Boar in Europe—A Review	101
The Pro-Inflammatory Chemokines CXCL9, CXCL10 and CXCL11 Are Upregulated Following SARS-CoV-2 Infection in an AKT-Dependent Manner	101
Broad-Spectrum Antiviral Strategies and Nucleoside Analogues	100
Neutralizing Antibody Therapeutics for COVID-19	99
Lentiviral Vector Bioprocessing	96
The Spike of Concern—The Novel Variants of SARS-CoV-2	96
Persistent Human Papillomavirus Infection	91
The Safety and Toxicity of Phage Therapy: A Review of Animal and Clinical Studies	90
Molecular Basis of Epstein–Barr Virus Latency Establishment and Lytic Reactivation	87
Liquid Biomolecular Condensates and Viral Lifecycles: Review and Perspectives	87
Antiviral Activity Exerted by Natural Products against Human Viruses	85
SARS-CoV-2, CT-Values, and Infectivity—Conclusions to Be Drawn from Side Observations	85
Natural and Experimental SARS-CoV-2 Infection in Domestic and Wild Animals	83
Recombination in Coronaviruses, with a Focus on SARS-CoV-2	80
Mutation Rates, Mutation Frequencies, and Proofreading-Repair Activities in RNA Virus Genetics	80
SARS-CoV-2 Survival on Surfaces and the Effect of UV-C Light	80
Clinical Update of Severe Fever with Thrombocytopenia Syndrome	78
Current Developments and Challenges in Plant Viral Diagnostics: A Systematic Review	78
A Review on Chikungunya Virus Epidemiology, Pathogenesis and Current Vaccine Development	78
Neutralizing Antibodies in COVID-19 Patients and Vaccine Recipients after Two Doses of BNT162b2	77
Monkeypox: A Comprehensive Review	76
Crystal Structure of SARS-CoV-2 Main Protease in Complex with the Non-Covalent Inhibitor ML188	75
Biological and Clinical Consequences of Integrin Binding via a Rogue RGD Motif in the SARS CoV-2 Spike Protein	74
SARS-CoV-2 Variant of Concern 202012/01 Has about Twofold Replicative Advantage and Acquires Concerning Mutations	72
A Case of Phage Therapy against Pandrug-Resistant Achromobacter xylosoxidans in a 12-Year-Old Lung-Transplanted Cystic Fibrosis Patient	72
Neuroinvasion and Neurotropism by SARS-CoV-2 Variants in the K18-hACE2 Mouse	71
Evolution of SARS-CoV-2 Envelope, Membrane, Nucleocapsid, and Spike Structural Proteins from the Beginning of the Pandemic to September 2020: A Global and Regional Approach by Epidemiological Week	71
Viral Vectors for COVID-19 Vaccine Development	71
Impact of SARS-CoV-2 Epidemic on Antimicrobial Resistance: A Literature Review	70
ASFV-G-∆I177L as an Effective Oral Nasal Vaccine against the Eurasia Strain of Africa Swine Fever	70
The Spread of SARS-CoV-2 Variant Omicron with a Doubling Time of 2.0–3.3 Days Can Be Explained by Immune Evasion	69
An Update of Orthopoxvirus Molecular Evolution	69
ABO Blood Types and COVID-19: Spurious, Anecdotal, or Truly Important Relationships? A Reasoned Review of Available Data	69
Inactivation of Human Coronavirus by Titania Nanoparticle Coatings and UVC Radiation: Throwing Light on SARS-CoV-2	68
Mucosal Vaccines, Sterilizing Immunity, and the Future of SARS-CoV-2 Virulence	68
Clinical Characterization and Genomic Analysis of Samples from COVID-19 Breakthrough Infections during the Second Wave among the Various States of India	68
World-Wide Prevalence and Genotype Distribution of Enteroviruses	68
Current Trend in Antiviral Therapy for Chronic Hepatitis B	68
The Remarkable Evolutionary Plasticity of Coronaviruses by Mutation and Recombination: Insights for the COVID-19 Pandemic and the Future Evolutionary Paths of SARS-CoV-2	68
Hepatitis A: Epidemiology, High-Risk Groups, Prevention and Research on Antiviral Treatment	68
LAMP-Coupled CRISPR–Cas12a Module for Rapid and Sensitive Detection of Plant DNA Viruses	67
A Contemporary Systematic Review on Repartition of HPV-Positivity in Oropharyngeal Cancer Worldwide	67
Lentiviral Vectors for T Cell Engineering: Clinical Applications, Bioprocessing and Future Perspectives	66
Block-And-Lock: New Horizons for a Cure for HIV-1	66
Jumbo Phages: A Comparative Genomic Overview of Core Functions and Adaptions for Biological Conflicts	66
SARS-CoV-2 T Cell Responses Elicited by COVID-19 Vaccines or Infection Are Expected to Remain Robust against Omicron	65
Current Drugs to Treat Infections with Herpes Simplex Viruses-1 and -2	65

Viral Infections and Systemic Lupus Erythematosus: New Players in an Old Story	64
SARS-CoV-2 Disinfection of Air and Surface Contamination by TiO2 Photocatalyst-Mediated Damage to Viral Morphology, RNA, and Protein	63
SARS-CoV-2 Infections in Animals: Reservoirs for Reverse Zoonosis and Models for Study	63
Antibody-Mediated Neutralization of Authentic SARS-CoV-2 B.1.617 Variants Harboring L452R and T478K/E484Q	62
Lentiviral Vectors for Delivery of Gene-Editing Systems Based on CRISPR/Cas: Current State and Perspectives	62
Antiviral Activity of Vitis vinifera Leaf Extract against SARS-CoV-2 and HSV-1	62
Anthropogenic Infection of Cats during the 2020 COVID-19 Pandemic	62
Lead SARS-CoV-2 Candidate Vaccines: Expectations from Phase III Trials and Recommendations Post-Vaccine Approval	62
Adenovirus Biology, Recombinant Adenovirus, and Adenovirus Usage in Gene Therapy	62
Antiviral Bioactive Compounds of Mushrooms and Their Antiviral Mechanisms: A Review	61
Estimation of Serial Interval and Reproduction Number to Quantify the Transmissibility of SARS-CoV-2 Omicron Variant in South Korea	61
Synthetic Messenger RNA-Based Vaccines: From Scorn to Hype	61
Monitoring Natural SARS-CoV-2 Infection in Lions (Panthera leo) at the Barcelona Zoo: Viral Dynamics and Host Responses	60
Structural Analysis of Neutralizing Epitopes of the SARS-CoV-2 Spike to Guide Therapy and Vaccine Design Strategies	60
Completion of the AAV Structural Atlas: Serotype Capsid Structures Reveals Clade-Specific Features	59
SARS-CoV-2 Infection: New Molecular, Phylogenetic, and Pathogenetic Insights. Efficacy of Current Vaccines and the Potential Risk of Variants	59
SARS-CoV-2 Vaccine Willingness among Pregnant and Breastfeeding Women during the First Pandemic Wave: A Cross-Sectional Study in Switzerland	59
HBV-Integration Studies in the Clinic: Role in the Natural History of Infection	59
Intranasal Infection of Ferrets with SARS-CoV-2 as a Model for Asymptomatic Human Infection	59
Hepatitis B Virus-Associated Hepatocellular Carcinoma	58
The Fatty Acid Lipid Metabolism Nexus in COVID-19	58
The Not-So-Good, the Bad and the Ugly: HPV E5, E6 and E7 Oncoproteins in the Orchestration of Carcinogenesis	57
Detection and Genome Sequencing of SARS-CoV-2 in a Domestic Cat with Respiratory Signs in Switzerland	57
Disease Pandemics and Major Epidemics Arising from New Encounters between Indigenous Viruses and Introduced Crops	57
Multiple Reassortants of H5N8 Clade 2.3.4.4b Highly Pathogenic Avian Influenza Viruses Detected in South Korea during the Winter of 2020–2021	57
Detection of Highly Pathogenic Avian Influenza Virus H5N1 Clade 2.3.4.4b in Great Skuas: A Species of Conservation Concern in Great Britain	57
TMPRSS11D and TMPRSS13 Activate the SARS-CoV-2 Spike Protein	57
Sialic Acid Receptors: The Key to Solving the Enigma of Zoonotic Virus Spillover	57
Site-Specific O-Glycosylation Analysis of SARS-CoV-2 Spike Protein Produced in Insect and Human Cells	57
Diagnostic SARS-CoV-2 Cycle Threshold Value Predicts Disease Severity, Survival, and Six-Month Sequelae in COVID-19 Symptomatic Patients	56
Viral Vectors in Gene Therapy: Where Do We Stand in 2023?	56
Viral Shrimp Diseases Listed by the OIE: A Review	56
In Vitro and In Vivo Models for Studying SARS-CoV-2, the Etiological Agent Responsible for COVID-19 Pandemic	56
Lymphopenia Caused by Virus Infections and the Mechanisms Beyond	56
Mechanism of Hepatitis B Virus cccDNA Formation	56
SARS-CoV-2: Evolution and Emergence of New Viral Variants	56
Dysregulated Interferon Response Underlying Severe COVID-19	56
Mosquito Vector Competence for Japanese Encephalitis Virus	56
Modeling within-Host SARS-CoV-2 Infection Dynamics and Potential Treatments	55
Structures and Functional Diversities of ASFV Proteins	54
A Review on Extrahepatic Manifestations of Chronic Hepatitis C Virus Infection and the Impact of Direct-Acting Antiviral Therapy	54
Antiviral Drug Discovery for the Treatment of COVID-19 Infections	54
Target Product Profile Analysis of COVID-19 Vaccines in Phase III Clinical Trials and Beyond: An Early 2021 Perspective	53
SARS-CoV-2 Reverse Zoonoses to Pumas and Lions, South Africa	53
ViralRecall—A Flexible Command-Line Tool for the Detection of Giant Virus Signatures in ‘Omic Data	53
HIV Protease: Historical Perspective and Current Research	53
ACE2-Independent Alternative Receptors for SARS-CoV-2	52
Viroplasms: Assembly and Functions of Rotavirus Replication Factories	51
SARS-CoV-2 N Protein Targets TRIM25-Mediated RIG-I Activation to Suppress Innate Immunity	51
Resveratrol and Pterostilbene Inhibit SARS-CoV-2 Replication in Air–Liquid Interface Cultured Human Primary Bronchial Epithelial Cells	51
Successful Treatment of Staphylococcus aureus Prosthetic Joint Infection with Bacteriophage Therapy	51
SARS-CoV-2 Serum Neutralization Assay: A Traditional Tool for a Brand-New Virus	51
African Swine Fever Virus (ASFV): Biology, Genomics and Genotypes Circulating in Sub-Saharan Africa	50
Berberine and Obatoclax Inhibit SARS-Cov-2 Replication in Primary Human Nasal Epithelial Cells In Vitro	50
APOBECs and Herpesviruses	50
Dengue Virus Infection: A Tale of Viral Exploitations and Host Responses	50
Clinical Severity of SARS-CoV-2 Omicron Variant Compared with Delta among Hospitalized COVID-19 Patients in Belgium during Autumn and Winter Season 2021–2022	50
Pseudorabies Virus: From Pathogenesis to Prevention Strategies	49
Persistent SARS-CoV-2 Infection, EBV, HHV-6 and Other Factors May Contribute to Inflammation and Autoimmunity in Long COVID	49
Detection of SARS-CoV-2 from Saliva as Compared to Nasopharyngeal Swabs in Outpatients	49
Turmeric Root and Its Bioactive Ingredient Curcumin Effectively Neutralize SARS-CoV-2 In Vitro	49
HIV-1 Entry and Membrane Fusion Inhibitors	49
Evaluation of the Safety Profile of the ASFV Vaccine Candidate ASFV-G-ΔI177L	49
Porcine Epidemic Diarrhea Virus: An Updated Overview of Virus Epidemiology, Virulence Variation Patterns and Virus–Host Interactions	49
Prevention and Control Strategies of African Swine Fever and Progress on Pig Farm Repopulation in China	49
ViralFlow: A Versatile Automated Workflow for SARS-CoV-2 Genome Assembly, Lineage Assignment, Mutations and Intrahost Variant Detection	49
Application of Oxford Nanopore Technology to Plant Virus Detection	48
PhageLeads: Rapid Assessment of Phage Therapeutic Suitability Using an Ensemble Machine Learning Approach	48
Human Cytomegalovirus and Autoimmune Diseases: Where Are We?	48
The Clinical Efficacy and Safety of Anti-Viral Agents for Non-Hospitalized Patients with COVID-19: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials	48
Nosocomial Outbreak of SARS-CoV-2 in a “Non-COVID-19” Hospital Ward: Virus Genome Sequencing as a Key Tool to Understand Cryptic Transmission	48
Relationships between Viral Load and the Clinical Course of COVID-19	48
Uncovering the Burden of Dengue in Africa: Considerations on Magnitude, Misdiagnosis, and Ancestry	48
The Main Molecular and Serological Methods for Diagnosing COVID-19: An Overview Based on the Literature	48
The Human Virome: Viral Metagenomics, Relations with Human Diseases, and Therapeutic Applications	48
Illuminating the Plant Rhabdovirus Landscape through Metatranscriptomics Data	48
An Updated Review on SARS-CoV-2 Infection in Animals	48
Potential Autoimmunity Resulting from Molecular Mimicry between SARS-CoV-2 Spike and Human Proteins	48
Immunopathology of RSV: An Updated Review	47
Persistent Detection and Infectious Potential of SARS-CoV-2 Virus in Clinical Specimens from COVID-19 Patients	47

Population Difference in Allele Frequency of HLA-C*05 and Its Correlation with COVID-19 Mortality	47
Intra-Host Diversity of SARS-Cov-2 Should Not Be Neglected: Case of the State of Victoria, Australia	47
Hepatitis B Virus DNA Integration: In Vitro Models for Investigating Viral Pathogenesis and Persistence	47
Replicating Viral Vector-Based Vaccines for COVID-19: Potential Avenue in Vaccination Arena	47
Resistance of SARS-CoV-2 Omicron BA.1 and BA.2 Variants to Vaccine-Elicited Sera and Therapeutic Monoclonal Antibodies	47
Innate Immune Responses to Influenza Virus Infections in the Upper Respiratory Tract	47
Viral and Bacterial Co-Infections in the Lungs: Dangerous Liaisons	47
Noroviruses—The State of the Art, Nearly Fifty Years after Their Initial Discovery	46
The Effect of Prophylactic HPV Vaccines on Oral and Oropharyngeal HPV Infection—A Systematic Review	46
Risk Factors of Severe COVID-19: A Review of Host, Viral and Environmental Factors	46
Integrase Strand Transfer Inhibitors Are Effective Anti-HIV Drugs	46
SARS-CoV-2 Subgenomic RNAs: Characterization, Utility, and Perspectives	46
In Vitro Techniques and Measurements of Phage Characteristics That Are Important for Phage Therapy Success	46
The Role of Viral Infections in the Onset of Autoimmune Diseases	46
SARS-CoV-2 Delta Variant Pathogenesis and Host Response in Syrian Hamsters	46
Current Clinical Landscape and Global Potential of Bacteriophage Therapy	45
Oral Antiviral Treatment for COVID-19: A Comprehensive Review on Nirmatrelvir/Ritonavir	45
Prognostic Values of Serum Ferritin and D-Dimer Trajectory in Patients with COVID-19	45
Multiple Introductions Followed by Ongoing Community Spread of SARS-CoV-2 at One of the Largest Metropolitan Areas of Northeast Brazil	45
The Ecology of Nipah Virus in Bangladesh: A Nexus of Land-Use Change and Opportunistic Feeding Behavior in Bats	45
SARS-like Coronaviruses in Horseshoe Bats (Rhinolophus spp.) in Russia, 2020	45
Fatal Neurodissemination and SARS-CoV-2 Tropism in K18-hACE2 Mice Is Only Partially Dependent on hACE2 Expression	45
Recombinant ASF Live Attenuated Virus Strains as Experimental Vaccine Candidates	44
Hemagglutinin Stability and Its Impact on Influenza A Virus Infectivity, Pathogenicity, and Transmissibility in Avians, Mice, Swine, Seals, Ferrets, and Humans	44
Nanotechnology as a Shield against COVID-19: Current Advancement and Limitations	44
Therapy Implications of Hepatitis C Virus Genetic Diversity	44
Epidemiology of Respiratory Infections during the COVID-19 Pandemic	44
Barriers towards HPV Vaccinations for Boys and Young Men: A Narrative Review	44
Monkeypox, a Literature Review: What Is New and Where Does This concerning Virus Come From?	44
Reproduction Number of the Omicron Variant Triples That of the Delta Variant	44
SARS-CoV-2 and Placenta: New Insights and Perspectives	43
JAK-STAT Pathway: A Novel Target to Tackle Viral Infections	43
The RNA Architecture of the SARS-CoV-2 3′-Untranslated Region	43
The Roles of Neutrophils in Cytokine Storms	43
Polysaccharides and Their Derivatives as Potential Antiviral Molecules	43
miRNAs as Potential Biomarkers for Viral Hepatitis B and C	43
A Critical Analysis of the Use of Cilgavimab plus Tixagevimab Monoclonal Antibody Cocktail (Evusheld™) for COVID-19 Prophylaxis and Treatment	43
Evaluation of the Stability of Bacteriophages in Different Solutions Suitable for the Production of Magistral Preparations in Belgium	43
Global Disparities in Hepatitis B Elimination—A Focus on Africa	43
Designing Lentiviral Vectors for Gene Therapy of Genetic Diseases	43
Imbalanced Immune Response of T-Cell and B-Cell Subsets in Patients with Moderate and Severe COVID-19	42
The Impact on Infectivity and Neutralization Efficiency of SARS-CoV-2 Lineage B.1.351 Pseudovirus	42
Rotaviruses: From Pathogenesis to Disease Control—A Critical Review	42
Recent Advances in Bunyavirus Glycoprotein Research: Precursor Processing, Receptor Binding and Structure	42
Adenovirus Core Proteins: Structure and Function	42
Molecular Insights into the Flavivirus Replication Complex	42
Amantadine Inhibits SARS-CoV-2 In Vitro	42
First Evidence of West Nile Virus Overwintering in Mosquitoes in Germany	42
Occult Hepatitis B Virus Infection: An Update	42
COVID-19 at a Glance: An Up-to-Date Overview on Variants, Drug Design and Therapies	42
Multiple Human Papilloma Virus (HPV) Infections Are Associated with HSIL and Persistent HPV Infection Status in Korean Patients	42
Xeno-Nucleic Acid (XNA) 2’-Fluoro-Arabino Nucleic Acid (FANA) Aptamers to the Receptor-Binding Domain of SARS-CoV-2 S Protein Block ACE2 Binding	42
One Health Investigation of SARS-CoV-2 Infection and Seropositivity among Pets in Households with Confirmed Human COVID-19 Cases—Utah and Wisconsin, 2020	42
Deletion of the L7L-L11L Genes Attenuates ASFV and Induces Protection against Homologous Challenge	42
The Spike Glycoprotein of SARS-CoV-2 Binds to β1 Integrins Expressed on the Surface of Lung Epithelial Cells	42
Spike Proteins of SARS-CoV-2 Induce Pathological Changes in Molecular Delivery and Metabolic Function in the Brain Endothelial Cells	42
Emergence of E484K Mutation Following Bamlanivimab Monotherapy among High-Risk Patients Infected with the Alpha Variant of SARS-CoV-2	41
Phage Therapy Related Microbial Succession Associated with Successful Clinical Outcome for a Recurrent Urinary Tract Infection	41
Screening of FDA-Approved Drugs Using a MERS-CoV Clinical Isolate from South Korea Identifies Potential Therapeutic Options for COVID-19	41
SARS-CoV-2 Infection in Dogs and Cats from Southern Germany and Northern Italy during the First Wave of the COVID-19 Pandemic	41
From A to m6A: The Emerging Viral Epitranscriptome	41
Common Oral Medications Lead to Prophage Induction in Bacterial Isolates from the Human Gut	41
Quinine Inhibits Infection of Human Cell Lines with SARS-CoV-2	41
Cytomegalovirus Infection and Inflammation in Developing Brain	41
Focus on HPV Infection and the Molecular Mechanisms of Oral Carcinogenesis	41
Curing Cats with Feline Infectious Peritonitis with an Oral Multi-Component Drug Containing GS-441524	41
Hyperinflammatory Response in COVID-19: A Systematic Review	41
Vascular Inflammation Is Associated with Loss of Aquaporin 1 Expression on Endothelial Cells and Increased Fluid Leakage in SARS-CoV-2 Infected Golden Syrian Hamsters	40
Analytical Sensitivity of Six SARS-CoV-2 Rapid Antigen Tests for Omicron versus Delta Variant	40
Japanese Encephalitis Virus: The Emergence of Genotype IV in Australia and Its Potential Endemicity	40
Enteric Viruses and Inflammatory Bowel Disease	40
Putative Novel Atypical BTV Serotype ‘36’ Identified in Small Ruminants in Switzerland	40
Functions of Coronavirus Accessory Proteins: Overview of the State of the Art	40
Bacteriophage Rescue Therapy of a Vancomycin-Resistant Enterococcus faecium Infection in a One-Year-Old Child following a Third Liver Transplantation	40
Standard Bacteriophage Purification Procedures Cause Loss in Numbers and Activity	40
Vaccinia-Virus-Based Vaccines Are Expected to Elicit Highly Cross-Reactive Immunity to the 2022 Monkeypox Virus	40
A pre- and during Pandemic Survey of Sars-Cov-2 Infection in Stray Colony and Shelter Cats from a High Endemic Area of Northern Italy	40
Discovery and Genetic Characterization of Novel Paramyxoviruses Related to the Genus Henipavirus in Crocidura Species in the Republic of Korea	40
Superiority of MALDI-TOF Mass Spectrometry over Real-Time PCR for SARS-CoV-2 RNA Detection	40
Re-Invasion of H5N8 High Pathogenicity Avian Influenza Virus Clade 2.3.4.4b in Hokkaido, Japan, 2020	40
SARS-CoV-2 Spike Protein S1-Mediated Endothelial Injury and Pro-Inflammatory State Is Amplified by Dihydrotestosterone and Prevented by Mineralocorticoid Antagonism	40
mRNA Vaccine Development for Emerging Animal and Zoonotic Diseases	40
Influence of Host Sialic Acid Receptors Structure on the Host Specificity of Influenza Viruses	39
HSV-1 DNA Replication—Coordinated Regulation by Viral and Cellular Factors	39
Human Defensins Inhibit SARS-CoV-2 Infection by Blocking Viral Entry	39
Development of a Cell-Based Luciferase Complementation Assay for Identification of SARS-CoV-2 3CLpro Inhibitors	39
The Role of Ubiquitination in NF-κB Signaling during Virus Infection	39
A Look into Bunyavirales Genomes: Functions of Non-Structural (NS) Proteins	39
Putative Novel Serotypes ‘33’ and ‘35’ in Clinically Healthy Small Ruminants in Mongolia Expand the Group of Atypical BTV	39
HERC5 and the ISGylation Pathway: Critical Modulators of the Antiviral Immune Response	39
Antivirals against the Chikungunya Virus	39
PEDV: Insights and Advances into Types, Function, Structure, and Receptor Recognition	39
Inhibitors of Protein Glycosylation Are Active against the Coronavirus Severe Acute Respiratory Syndrome Coronavirus SARS-CoV-2	39
Thapsigargin Is a Broad-Spectrum Inhibitor of Major Human Respiratory Viruses: Coronavirus, Respiratory Syncytial Virus and Influenza A Virus	39
Zoonotic Animal Influenza Virus and Potential Mixing Vessel Hosts	39